Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:58:20 EDT Sun 05 May 2024
Enter Symbol
or Name
USA
CA



News for U:RSPI from 2023-05-04 to 2024-05-03 - 8 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-03-20 08:30U:RSPINews ReleaseRespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury
2024-02-13 08:30U:RSPINews ReleaseRespireRx Pharmaceuticals Inc. Reports Preclinical Pain Relief for their Non-Opioid Lead GABAkine
2024-01-22 08:30U:RSPINews ReleaseRespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
2024-01-04 08:45U:RSPINews ReleaseRespireRx Pharmaceuticals Inc. Announces the Publication of a Case Report in which KRM-II-81 Totally Suppressed Epileptiform Activity in Brain Tissue Surgically Removed from Epileptic Patient
2023-12-11 08:30U:RSPINews ReleaseRespireRx Pharmaceuticals Inc. Announces Agreement with Ponto Ventures to Drive Business Development with Will Clodfelter as RespireRx Part-Time Senior VP of Business Development
2023-10-12 08:45U:RSPINews ReleaseRespireRx Pharmaceuticals Inc. ¢ € ™s Subsidiary ResolutionRx Ltd Enters into Master Services Agreement for Dronabinol Manufacturing and Related Services
2023-08-09 08:50U:RSPINews ReleaseRespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
2023-05-24 08:30U:RSPINews ReleaseResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs